CATO
The Cato Corporation
There isn't enough reported data to score CATO yet.
LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
CATO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Strong |
CATO's balance sheet is currently strong, and its revenue, profitability and cash flow are stable.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CATO PE Valuation
CATO has no meaningful PE right now: it lost money over the past year.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
CATO Forward outlook
There aren't enough analyst estimates for CATO to show an outlook.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CATO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.30 | +$0.70 |
| Q2 2026 | -$0.01 | +$1.33 |
| Q1 2026 | -$0.31 | +$0.66 |
| Q4 2025 | -$0.49 | +$0.90 |
| Q3 2025 | -$1.00 | -$0.10 |
| Q2 2025 | -$1.34 | -$0.49 |
| Q1 2025 | -$0.97 | +$0.20 |
| Q4 2024 | -$1.39 | -$1.23 |
CATO is still losing money, but far less than before: $0.30 per share over the past year, against $2.01 at its worst in early 2021.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
CATO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $165.5M | -6.2% |
| Q2 2026 | $171.1M | +0.5% |
| Q1 2026 | $151.7M | -4% |
| Q4 2025 | $155.4M | +6.3% |
| Q3 2025 | $176.5M | +4.7% |
| Q2 2025 | $170.2M | -3.9% |
| Q1 2025 | $157.9M | -9.7% |
| Q4 2024 | $146.2M | -7.6% |
CATO's revenue fell from its 2021 peak and has held roughly level since: $166M last quarter, down 6.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.4% | -3.5 points |
| Q2 2026 | 5.2% | +3.2 points |
| Q1 2026 | -8.9% | +6.3 points |
| Q4 2025 | -5.3% | +4.8 points |
| Q3 2025 | 3.1% | +2.7 points |
| Q2 2025 | 2% | -4.5 points |
| Q1 2025 | -15% | -8 points |
| Q4 2024 | -10% | -3.5 points |
CATO has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over CATO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
CATO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $13.1M | +26% |
| Q2 2026 | $7M | +145% |
| Q1 2026 | -$5.6M | +$2.3M |
| Q4 2025 | -$12.9M | +$10.9M |
| Q3 2025 | $10.4M | +555% |
| Q2 2025 | $2.8M | +17% |
| Q1 2025 | -$7.8M | +$5.6M |
| Q4 2024 | -$23.8M | -$12.1M |
CATO has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
CATO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1% | +182K shares |
| 1 year | +1% | +191K shares |
| 3 years | -2% | -395K shares |
| 5 years | -11% | -2.4M shares |
| Available history | -20% | -4.7M shares |
CATO has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $111,000 |
| Q2 2026 | $311,000 |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $60,000 |
| Q2 2025 | $935,000 |
| Q1 2025 | $1.5M |
| Q4 2024 | $161,000 |
CATO spent $422,000 buying back its own shares over the past year, down 84% from the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
CATO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -10.1x | Net Cash |
| Q2 2024 | -48.5x | Net Cash |
| Q4 2023 | -5.6x | Net Cash |
| Q3 2023 | -9.2x | Net Cash |
| Q2 2023 | -5.4x | Net Cash |
| Q1 2023 | -1.6x | Net Cash |
| Q4 2022 | -1.6x | Net Cash |
| Q3 2022 | -1.3x | Net Cash |
CATO has more cash than debt.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CATO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 2.2 | Oversold |
CATO's weekly RSI is 33 (neutral) and its Stochastic is 2 (oversold).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
CATO PE vs Consumer Cyclical Sector
| Metric | CATO | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
CATO has no meaningful PE right now: it lost money over the past year.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
CATO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.36 | 3.8% below |
| 20 week MA | $2.77 | 18% below |
| 50 week MA | $2.97 | 24% below |
| 100 week MA | $3.16 | 28% below |
| 200 week MA | $4.98 | 54% below |
CATO is in a downtrend: it's below all five of its weekly moving averages, and 54% below its 200-week average.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
CATO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.2 | $8.20 | -52% |
| 2021 | $8.20 | $16.9 | +106% |
| 2022 | $16.9 | $9.18 | -46% |
| 2023 | $9.18 | $7.14 | -22% |
| 2024 | $7.14 | $3.93 | -45% |
| 2025 | $3.93 | $3.08 | -22% |
| 2026 YTD | $3.08 | $2.27 | -26% |
CATO has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.